BioCentury | Dec 15, 2016
Product R&D
p53 and Ras: Back from the dead
...wild-type p53 to the tumor. In addition, a recombinant adenoviral vector-based p53 gene therapy from Shenzhen SiBiono GeneTech Co. Ltd....
...Princeton University, Princeton, N.J. PMV Pharmaceuticals Inc., Redwood City, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Shenzhen SiBiono GeneTech Co. Ltd....
...Princeton University, Princeton, N.J. PMV Pharmaceuticals Inc., Redwood City, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Shenzhen SiBiono GeneTech Co. Ltd....
